Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sen. Snowe's Vote For Senate Finance Bill Narrows Overall Public Plan Options

This article was originally published in The Pink Sheet Daily

Executive Summary

Republican Senator has long said she will oppose bill with a public insurance plan.

You may also be interested in...



Elimination Of Tax Deferral On Foreign Income Still A "Valid Concern," J&J Says

Efforts to eliminate a tax deferral on income generated by multinationals overseas and healthcare reform would be a one-two punch to Big Pharma.

Elimination Of Tax Deferral On Foreign Income Still A "Valid Concern," J&J Says

Efforts to eliminate a tax deferral on income generated by multinationals overseas and healthcare reform would be a one-two punch to Big Pharma.

Public Plan: Will Snowe Pull The Trigger?

The legislative prospects for a provision triggering a public insurance plan if affordability thresholds are not met remain uncertain, according to comments by moderate Republican Olympia Snowe

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS068593

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel